The 36-month beta value for ONVO is at 0.96. Analysts have varying views on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for ONVO is 17.16M, and currently, shorts hold a 8.01% of that float. The average trading volume for ONVO on March 19, 2025 was 7.90M shares.
ONVO) stock’s latest price update
Organovo Holdings Inc (NASDAQ: ONVO)’s stock price has decreased by -27.82 compared to its previous closing price of 0.40. However, the company has seen a -32.35% decrease in its stock price over the last five trading sessions. globenewswire.com reported 2025-03-19 that SAN DIEGO, March 19, 2025 (GLOBE NEWSWIRE) — Organovo Holdings, Inc. (Nasdaq: ONVO), a clinical stage biotechnology company focused on developing novel treatment approaches in inflammatory bowel disease (IBD), today announced that it will effect a 1-for-12 reverse stock split of its issued and outstanding common stock that will become effective at 5:00 p.m. Eastern Time on Thursday, March 20, 2025. Organovo’s common stock will commence trading on a reverse stock split-adjusted basis at the opening of the market on Friday, March 21, 2025.
ONVO’s Market Performance
ONVO’s stock has fallen by -32.35% in the past week, with a monthly drop of -23.48% and a quarterly drop of -27.94%. The volatility ratio for the week is 7.33% while the volatility levels for the last 30 days are 22.13% for Organovo Holdings Inc The simple moving average for the last 20 days is -44.83% for ONVO stock, with a simple moving average of -44.25% for the last 200 days.
Analysts’ Opinion of ONVO
Many brokerage firms have already submitted their reports for ONVO stocks, with H.C. Wainwright repeating the rating for ONVO by listing it as a “Buy.” The predicted price for ONVO in the upcoming period, according to H.C. Wainwright is $2.50 based on the research report published on December 13, 2018 of the previous year 2018.
ONVO Trading at -32.84% from the 50-Day Moving Average
After a stumble in the market that brought ONVO to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -84.07% of loss for the given period.
Volatility was left at 22.13%, however, over the last 30 days, the volatility rate increased by 7.33%, as shares sank -23.00% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -36.13% lower at present.
During the last 5 trading sessions, ONVO fell by -32.65%, which changed the moving average for the period of 200-days by -70.31% in comparison to the 20-day moving average, which settled at $0.5283. In addition, Organovo Holdings Inc saw -36.61% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for ONVO
Current profitability levels for the company are sitting at:
- -102.93 for the present operating margin
- -0.19 for the gross margin
The net margin for Organovo Holdings Inc stands at -101.52. The total capital return value is set at -13.85. Equity return is now at value -378.40, with -194.66 for asset returns.
Based on Organovo Holdings Inc (ONVO), the company’s capital structure generated 0.74 points at debt to capital in total, while cash flow to debt ratio is standing at -9.53. The debt to equity ratio resting at 2.91. The interest coverage ratio of the stock is -2511.6.
Currently, EBITDA for the company is -14.81 million with net debt to EBITDA at 0.01. When we switch over and look at the enterprise to sales, we see a ratio of 39.3. The receivables turnover for the company is 4.69for trailing twelve months and the total asset turnover is 0.03. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.72.
Conclusion
In conclusion, Organovo Holdings Inc (ONVO) has had a bad performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
